PDGF receptor tyrosine kinase inhibitor suppresses mesangial cell proliferation involving STAT3 activation

Mesangial Cell ◽

Kinase Inhibitor ◽

Pdgf Receptor ◽

Mesangial Cell Proliferation

The Synergistic Action of a VEGF-Receptor Tyrosine-Kinase Inhibitor and a Sensitizing PDGF-Receptor Blocker Depends upon the Stage of Vascular Maturation

Microcirculation ◽

10.1080/10739680701370021 ◽

2007 ◽

Vol 14 (8) ◽

pp. 813-825 ◽

Cited By ~ 17

Author(s):

Ruslan Hlushchuk ◽

Oliver Baum ◽

Guenther Gruber ◽

Jeanette Wood ◽

Valentin Djonov

Keyword(s):

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Synergistic Action ◽

Receptor Blocker ◽

Vegf Receptor ◽

Pdgf Receptor ◽

Vascular Maturation

Restenosis Following Angioplasty in the Swine Coronary Artery Is Inhibited By an Orally Active PDGF-Receptor Tyrosine Kinase Inhibitor, RPR101511A

Circulation ◽

10.1161/01.cir.99.25.3292 ◽

1999 ◽

Vol 99 (25) ◽

pp. 3292-3299 ◽

Cited By ~ 54

Author(s):

Glenda Bilder ◽

Tara Wentz ◽

Robert Leadley ◽

Dilip Amin ◽

Lisa Byan ◽

...

Keyword(s):

Coronary Artery ◽

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Pdgf Receptor ◽

Orally Active

Validation of in vivo pharmacodynamic activity of a novel PDGF receptor tyrosine kinase inhibitor using immunohistochemistry and quantitative image analysis

Molecular Cancer Therapeutics ◽

10.1158/1535-7163.mct-05-0004 ◽

2005 ◽

Vol 4 (8) ◽

pp. 1198-1204 ◽

Cited By ~ 8

Author(s):

Michael R. D'Andrea ◽

Jay M. Mei ◽

Robert W. Tuman ◽

Robert A. Galemmo ◽

Dana L. Johnson

Keyword(s):

Image Analysis ◽

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Quantitative Image Analysis ◽

Pdgf Receptor ◽

Quantitative Image

The Effect Of Masitinib, A C-kit/PDGF Receptor Tyrosine Kinase Inhibitor, On IgE And Ventilator Parameters In Experimental Feline Asthma

10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a4076 ◽

2011 ◽

Author(s):

Vamsi P. Guntur ◽

Tekla M. Lee-Fowler ◽

John Dodam ◽

Leah A. Cohn ◽

Amy E. DeClue ◽

...

Keyword(s):

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Pdgf Receptor ◽

Masitinib, a c-kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid-dependent asthmatics

Allergy ◽

10.1111/j.1398-9995.2009.02122.x ◽

2009 ◽

Vol 64 (8) ◽

pp. 1194-1201 ◽

Cited By ~ 87

Author(s):

M. Humbert ◽

F. de Blay ◽

G. Garcia ◽

A. Prud’homme ◽

C. Leroyer ◽

...

Keyword(s):

Tyrosine Kinase ◽

Disease Control ◽

Kinase Inhibitor ◽

Pdgf Receptor ◽

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor

10.32388/jfobd7 ◽

2020 ◽

Author(s):

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Epidermal Growth

Delayed Therapy with Receptor Tyrosine Kinase Inhibitor Nintedanib Diminished Chronic Rejection in a Murine Lung Transplant Model

10.1055/s-0041-1725623 ◽

2021 ◽

Author(s):

J. Mauer ◽

A. Kuckhahn ◽

J. Distler ◽

B. Spriewald ◽

M. Ramsperger-Gleixner ◽

...

Keyword(s):

Tyrosine Kinase ◽

Chronic Rejection ◽

Lung Transplant ◽

Kinase Inhibitor ◽

Murine Lung ◽

Transplant Model

Everolimus zur Behandlung des metastasierten Nierenzellkarzinoms nach Versagen der ersten VEGFr-TKI(Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor)-Therapie: Ergebnisse einer Interimsanalyse einer nichtinterventionellen Studie

Karger Kompass Onkologie ◽

10.1159/000356898 ◽

2014 ◽

Vol 1 (1) ◽

pp. 28-29

Keyword(s):

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Endothelial Growth Factor

Glomerular Changes in Rats Administered ABT-869, a Multitargeted Receptor Tyrosine Kinase Inhibitor - Linking Ultrastructure to Mechanism

Microscopy and Microanalysis ◽

10.1017/s1431927609097566 ◽

2009 ◽

Vol 15 (S2) ◽

pp. 16-17

Author(s):

J Fagerland ◽

S Morgan

Keyword(s):

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Extended abstract of a paper presented at Microscopy and Microanalysis 2009 in Richmond, Virginia, USA, July 26 – July 30, 2009

The effect of combination treatment with gemcitabine and the EGFR-receptor tyrosine kinase inhibitor iressa with photodynamic therapy in bladder cancer

European Urology Supplements ◽

10.1016/s1569-9056(03)80175-6 ◽

2003 ◽

Vol 2 (1) ◽

pp. 44

Author(s):

C.H. Briggs ◽

C.D. Betts ◽

K.J. O'Flynn ◽

J.V. Moore ◽

N.W. Clarke

Keyword(s):

Bladder Cancer ◽

Photodynamic Therapy ◽

Tyrosine Kinase ◽

Combination Treatment ◽

Kinase Inhibitor ◽